These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
550 related items for PubMed ID: 33238668
1. [Association of age-related white matter hyperintensity with brain atrophy and cognitive impairment in patients with Parkinson's disease]. Chen HM, Zhang MM, Wang YL. Zhonghua Yi Xue Za Zhi; 2020 Nov 24; 100(43):3397-3401. PubMed ID: 33238668 [Abstract] [Full Text] [Related]
2. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease. Ong M, Foo H, Chander RJ, Wen MC, Au WL, Sitoh YY, Tan L, Kandiah N. J Neurol Sci; 2017 Jun 15; 377():122-126. PubMed ID: 28477681 [Abstract] [Full Text] [Related]
3. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology. Gao Y, Nie K, Huang B, Mei M, Guo M, Xie S, Huang Z, Wang L, Zhao J, Zhang Y, Wang L. Neurosci Lett; 2017 Sep 29; 658():121-132. PubMed ID: 28823894 [Abstract] [Full Text] [Related]
4. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort. Hanning U, Teuber A, Lang E, Trenkwalder C, Mollenhauer B, Minnerup H. Parkinsonism Relat Disord; 2019 Dec 29; 69():61-67. PubMed ID: 31678722 [Abstract] [Full Text] [Related]
5. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease. Chahine LM, Dos Santos C, Fullard M, Scordia C, Weintraub D, Erus G, Rosenthal L, Davatzikos C, McMillan CT. Eur J Neurol; 2019 Feb 29; 26(2):246-e18. PubMed ID: 30169897 [Abstract] [Full Text] [Related]
6. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease. Pozorski V, Oh JM, Okonkwo O, Krislov S, Barzgari A, Theisen F, Sojkova J, Bendlin BB, Johnson SC, Gallagher CL. Neuroimage Clin; 2019 Feb 29; 23():101870. PubMed ID: 31150958 [Abstract] [Full Text] [Related]
11. The effect of small vessel disease on motor and cognitive function in Parkinson's disease. Shibata K, Sugiura M, Nishimura Y, Sakura H. Clin Neurol Neurosurg; 2019 Jul 29; 182():58-62. PubMed ID: 31078957 [Abstract] [Full Text] [Related]
12. White matter microstructural damage in small vessel disease is associated with Montreal cognitive assessment but not with mini mental state examination performances: vascular mild cognitive impairment Tuscany study. Pasi M, Salvadori E, Poggesi A, Ciolli L, Del Bene A, Marini S, Nannucci S, Pescini F, Valenti R, Ginestroni A, Toschi N, Diciotti S, Mascalchi M, Inzitari D, Pantoni L, VMCI Study Investigators. Stroke; 2015 Jan 29; 46(1):262-4. PubMed ID: 25395414 [Abstract] [Full Text] [Related]
19. Cortical thinning associated with mild cognitive impairment in Parkinson's disease. Segura B, Baggio HC, Marti MJ, Valldeoriola F, Compta Y, Garcia-Diaz AI, Vendrell P, Bargallo N, Tolosa E, Junque C. Mov Disord; 2014 Oct 29; 29(12):1495-503. PubMed ID: 25100674 [Abstract] [Full Text] [Related]
20. Correlation of Brain Perfusion with White Matter Hyperintensity, Brain Atrophy, and Cognition in Patients with Posterior Cerebral Artery Stenosis and Subjective Cognitive Decline. Liu M, Nie ZY, Li RR, Zhang W, Wang H, He YS, Zhao LJ, Li YX. Med Sci Monit; 2018 Aug 17; 24():5729-5738. PubMed ID: 30115900 [Abstract] [Full Text] [Related] Page: [Next] [New Search]